Physiologically based pharmacokinetic modeling of inhaled trichloroethylene and its oxidative metabolites in B6C3F1 mice

Toxicology and Applied Pharmacology

Volumn 154, Issue 3, 1999, Pages 264-278

  Greenberg, Marc S ^a,b   Burton Jr , G Allen ^b   Fisher, Jeffrey W ^a  

^a AIR FORCE RESEARCH LABORATORY   (United States)

^b WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Chloral hydrate; Dichloroacetic acid; Inhalation; Mice; PBPK; Trichloroacetic acid; Trichloroethanol; Trichloroethylene

Indexed keywords

TRICHLOROETHYLENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DRUG ABSORPTION; INHALATION; LIVER LEVEL; MALE; MOUSE; NONHUMAN; TISSUE DISTRIBUTION; TOXICOKINETICS;

ANIMALIA;

EID: 0032972477     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1998.8594     Document Type: Article

References (60)

1. Abbas R., Fisher J. W. A physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice. Toxicol. Appl. Pharmacol. 147:1997;15-30.
2. Abbas R. R., Seckel C. S., Kidney J. K., Fisher J. W. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos. 24:1996;1340-1346.
3. Abbas R. R., Seckel C. S., Kidney J. K., Fisher J. W. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice. Drug Metab. Dispos. 25:1997.
4. Allen B. C., Fisher J. W. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal. 13:1993;71-86.
5. ATSDR, 1993, Toxicological Profile for Trichloroethylene.
6. Axelson O., Selden A., Andersson K., Hogstedt C. Updated and expanded Swedish cohort study on trichloroethylene and cancer risk. J. Occup. Med. 36:1994;556-562.
7. Bruckner J. V., Davis B. D., Blancato J. N. Metabolism, toxicity, and carcinogenicity of trichloroethylene. Crit. Rev. Toxicol. 20:1989;31-50.
8. Buben J. A., O'Flaherty E. J. Delineation of the role of metabolism in the hepatotoxicity of trichloroethylene and perchloroethylene. A dose-effect study. Toxicol. Appl. Pharmacol. 78:1985;105-122.
9. Bull R. J., Sanchez I. M., Nelson M. A., Larson J. L., Lansing A. J. Liver tumor induction in B6C3F1 mice by dichloroacetate and trichloroacetate. Toxicology. 63:1990;341-359.
10. Clewell H. J. III, Gentry P. R., Gearhart J. M., Allen B. C., Andersen M. E. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere. 31:1995;2561-2578.
11. Dalbey W., Bingham E. Metabolism of trichloroethylene by the isolated perfused lung. Toxicol. Appl. Pharmacol. 43:1978;267-276.
12. Dallas C. E., Gallo J. M., Ramanathan R., Muralidhara S., Bruckner J. V. Physiological pharmacokinetic modeling of inhaled trichloroethylene in rats. Toxicol. Appl. Pharmacol. 110:1991;303-314.
13. Daniel F. B., DeAngelo A. B., Stober J. A., Olson G. R., Page N. P. Hepatocarcinogenicity of chloral hydrate, 2-chloroacetaldehyde, and dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Toxicol. 19:1992;159-168.
14. Davidson I. W. F., Beliles R. P. Consideration of the target organ toxicity of trichloroethylene in terms of metabolite toxicity and pharmacokinetics. Drug Metab. Rev. 23:1991;493-599.
15. DeAngelo A. B., Daniel F. B., Stober J. A., Olson G. R. The carcinogenicity of dichloroacetic acid in the male B6C3F1 mouse. Fundam. Appl. Pharmacol. 16:1991;337-347.
16. Dekant W., Metzler M., Henschler D. Novel metabolism of trichloroethylene through dechlorination reactions in rats, mice and humans. Biochem. Pharmacol. 33:1984;2021-2027.
17. Dekant W., Schultz M., Metzler M., Henschler D. Absorption, elimination and metabolism of trichloroethylene: A quantitative difference between rats and mice. Xenobiotica. 16:1986;143-150.
18. Dowsley T. F., Ulreich J. B., Forkert P. G. Bioactivation of 1,1-dichloroethylene to an epoxide in human lung and liver microsomes. Toxicologist. 42:1998.
19. Fisher J. W., Allen B. C. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. Risk Anal. 13:1993;87-95.
20. Fisher, J. W. Andersen, M. E. 1990, Using inhalation kinetic data in route-to-route extrapolation: A physiological model for oral absorption of trichloroethylene, Principles of Route-to-Route Extrapolation for Risk Assessment, 297, 311, Elsevier Science, New York.
21. Fisher J. W., Gargas M. L., Allen B. C., Andersen M. E. Physiologically based pharmacokinetic modeling with trichloroethylene and its metabolite, trichloroacetic acid in the rat and mouse. Toxicol. Appl. Pharmacol. 109:1991;183-195.
22. Fisher J. W., Mahle D., Abbas R. A human physiologically based pharmacokinetic model for trichloroethylene and its metabolites, trichloroacetic acid and free trichloroethanol. Toxicol. Appl. Pharmacol. 152:1998;339-359.
23. Fisher J. W., Whittaker T. A., Taylor D. H., Clewell H. J. III, Andersen M. E. Physiologically based pharmacokinetic modeling of the pregnant rat: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 99:1989;395-414.
24. Fisher J. W., Whittaker T. A., Taylor D. H., Clewell H. J. III, Andersen M. E. Physiologically based pharmacokinetic modeling of the lactating rat and nursing pup: A multiroute exposure model for trichloroethylene and its metabolite, trichloroacetic acid. Toxicol. Appl. Pharmacol. 102:1990;497-513.
25. Forkert P. G. CYP2E1 is preferentially expressed in clara cells of murine lung: Localization byin situ. Am. J. Respir. Cell Mol. Biol. 12:1995;589-596.
26. Forkert P. G. Localization of a reactive intermediate of 1,1-dichloroethylene in target clara cells in murine lung. Toxicologist. 42:1998.
27. Forkert P. G., Birch D. W. Pulmonary toxicity of trichloroethylene in mice: Covalent binding and morphological manifestations. Drug Metab. Dispos. 17:1989;106-113.
28. Forkert P. G., Forkert L. Trichloroethylene induces pulmonary fibrosis in mice. Can. J. Physiol. Pharmacol. 72:1994;205-210.
29. Forkert P. G., Dowsley T. F., Lee R. P., Hong J.-Y., Ulreich J. B. Differential formation of 1,1-dichloroethylene-metabolites in the lungs of adult and weanling male and female mice: Correlation with severity of bronchiolar cytotoxicity. J. Pharmacol. Exp. Ther. 279:1996;1484-1490.
30. Forkert P. G., Sylvestre P. L., Poland J. S. Lung injury induced by trichloroethylene. Toxicology. 35:1985;143-160.
31. Fukuda K., Takemoto K., Tsuruta H. Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind. Health. 21:1983;243-254.
32. Gargas M. L., Andersen M. L. Determining kinetic constants of chlorinated ethane metabolism in the rat from rates of exhalation. Toxicol. Appl. Pharmacol. 99:1989;344-353.
33. Gerde P., Dahl A. R. A model for the uptake of inhaled vapors in the nose of the dog during cyclic breathing. Toxicol. Appl. Pharmacol. 109:1991;276-288.
34. Green T., Mainwaring G. W., Foster J. R. Trichloroethylene-induced mouse lung tumors: Studies of the mode of action and comparisons between species. Fundam. Appl. Toxicol. 37:1997;125-130.
35. Green T., Prout M. S. Species differences in response to trichloroethylene: II. Biotransformation in rats and mice. Toxicol. Appl. Pharmacol. 79:1985;401-411.
36. Herren-Freund S. L., Pereira M. A., Khoury M. D., Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol. Appl. Pharmacol. 90:1987;183-188.
37. International Life Science Institute, Risk Science Institute, 1994, Physiological Parameters for PBPK Models. Report, December.
38. Johanson G. Modelling of respiratory exchange of polar solvents. Ann. Occup. Hyg. 35:1991;323-339.
39. Ketcha M. M., Warren D. A., Bishop C. T., Brashear W. T. Factors influencing the conversion of trichloroacetic acid to dichloroacetic acid in biological matrices. J. Anal. Toxicol. 20:1996;236-241.
40. Larson J. L., Bull R. J. Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice. Toxicol. Appl. Pharmacol. 115:1992a;268-277.
41. Larson J. L., Bull R. J. Species differences in the metabolism of trichloroethylene to the carcinogenic metabolites trichloroacetate and dichloroacetate. Toxicol. Appl. Pharmacol. 115:1992b;278-285.
42. Leach, L. J. 1963, A Laboratory Test Chamber for Studying Airborne Materials, 1, 12.
43. Lee K. M., Bruckner J. V., Muralidhara S., Gallo J. M. Characterization of presystemic elimination of trichloroethylene and its nonlinear kinetics in rats. Toxicol. Appl. Pharmacol. 139:1996;262-271.
44. Lewis G. D., Reynolds R. C., Johnson A. R. Some effects of trichloroethylene on mouse lungs and liver. Gen. Pharmacol. 15:1984;139-142.
45. Lipscomb J. C., Garrett C. M., Mahle D. A. Comparison of thein vitro. Toxicologist. 30:1996.
46. Maltoni C., Lefemine G., Cotti G. Experimental Research on Trichloroethylene Carcinogenesis. 1986;Princeton Scientific Publishing, Princeton.
47. Maltoni C., Lefemine G., Cotti G., Perino G. Long-term carcinogenicity bioassays on trichloroethylene administered by inhalation to Sprague-Dawley rats and Swiss and B6C3F1 mice. Ann. NY Acad. Sci. 354:1988;316-342.
48. Morris J. B., Cavanaugh D. G. Deposition of ethanol and acetone vapors in the upper respiratory tracts of the rat. Fundam. Appl. Pharmacol. 6:1986;78-88.
49. NTP (National Toxicology Program), 1990, Toxicology and Carcinogenesis Studies of Trichloroethylene (Without Epichlorohydrin), F344/N Rats and B6C3F1 Mice (Gavage Studies).
50. Odum J., Foster J. R., Green T. A mechanism for the development of clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem.-Biol. Interact. 83:1992;135-153.
51. Pastino G. M., Asgharian B., Roberts K., Medinsky M. A., Bond J. A. A comparison of physiologically based pharmacokinetic model predictions and experimental data for inhaled ethanol in male and female B6C3F1 mice, F344 rats, and humans. Toxicol. Appl. Pharmacol. 145:1997;147-157.
52. Perkins R. A., Ward K. W., Pollack G. M. A pharmacokinetic model of inhaled methanol in humans and comparison to methanol disposition in mice and rats. Environ. Health. Perspect. 103:1995;726-733.
53. Prout M. S., Provan W. M., Green T. Species differences in response to trichloroethylene: I. Pharmacokinetics in rats and mice. Toxicol. Appl. Pharmacol. 79:1985;389-400.
54. Spirtas R., Stewart P. A., Lee J. S., Marano D. E., Forbes C. D., Grauman D. J., Pettigrew H. M., Blair A., Hoover R. N., Cohen J. L. Retrospective cohort mortality study of workers at an aircraft maintenance facility. I. Epidemiological results. Br. J. Ind. Med. 48:1991;515-530.
55. Staats D. A., Fisher J. W., Connolly R. B. Gastrointestinal absorption of xenobiotics in physiologically based pharmacokinetic models: A two-compartment description. Drug Metab. Dispos. 19:1991;144-148.
56. Templin M. V., Parker J. C., Bull R. J. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 123:1993;1-8.
57. Templin M. V., Parker J. C., Bull R. J. Relative formation of dichloroacetate and trichloroacetate from trichloroethylene in male B6C3F1 mice. Toxicol. Appl. Pharmacol. 133:1995a;177.
58. Templin M. V., Stevens D. K., Stenner R. D., Bonate P. L., Tuman D., Bull R. J. Factors affecting species differences in the kinetics of metabolites of trichloroethylene. J. Toxicol. Environ. Health. 44:1995b;435-447.
59. USEPA (U.S. Environmental Protection Agency), 1985, Health Assessment Document for Trichloroethylene.
60. Vinegar A., Auten K. L., Seckel C. S., Reed Y. M., Conolly R. B. Physiologically based pharmacokinetic model of the metabolism of trichloroethylene by an isolated ventilated perfused lung. Inhal. Toxicol. 2:1990;285-294.